Sonoma和Medline利用微显微镜技术推出一个新的伤口净化器,在美国医院和家中提供,事实证明可以减少疼痛和感染。 Sonoma and Medline launch a new wound cleanser using Microcyn® tech, proven to reduce pain and infection, available in U.S. hospitals and homes.

索诺马制药公司和梅德林工业公司利用索诺马的微晶技术,在美国推出了一个新的低氯酸伤口净化器。 Sonoma Pharmaceuticals and Medline Industries have launched a new hypochlorous acid wound cleanser in the U.S., using Sonoma’s Microcyn® technology. 该产品可在医院和家庭保健机构获得,目的是促进愈合和减少感染,同时对健康组织是安全的。 The product, available in hospitals and home healthcare, aims to promote healing and reduce infection while being safe for healthy tissue. 通过2024年的合作发展起来,它得到了临床证据的支持,这些证据表明疼痛、痒痒和疤痕减少。 Developed through a 2024 collaboration, it is backed by clinical evidence showing reduced pain, itching, and scarring. Medline网络向全国分发清洁剂,Sonoma将其全球覆盖范围扩大到55个国家。 The cleanser is distributed nationwide through Medline’s network, with Sonoma expanding its global reach across 55 countries.